Sandra J. Horning

Medicine · Health Sciences

75h-index32.3kcitations307works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(247), Chronic Lymphocytic Leukemia Research(83), Viral-associated cancers and disorders(70), Lung Cancer Treatments and Mutations(63), CNS Lymphoma Diagnosis and Treatment(41)

Publications306 total

Related Article from Developing Standards for Breakthrough Therapy Designation in Oncology
2023Open Access
Supplementary Data from Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494
2023Open Access
Supplementary Data from Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494
2023Open Access
Data from Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494
2023Open Access
Supplementary Material from Developing Standards for Breakthrough Therapy Designation in Oncology
2023Open Access
Data from Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494
2023Open Access
Related Article from Developing Standards for Breakthrough Therapy Designation in Oncology
2023Open Access
Supplementary Material from Developing Standards for Breakthrough Therapy Designation in Oncology
2023Open Access
Data from Developing Standards for Breakthrough Therapy Designation in Oncology
2023Open Access
Data from Developing Standards for Breakthrough Therapy Designation in Oncology
2023Open Access
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902
Transfusion·2020· 4 citedOpen Access
Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
Journal for ImmunoTherapy of Cancer·2019· 23 citedOpen Access
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis
Cancer·2017· 58 citedOpen Access
A new cancer ecosystem
Science·2017· 26 cited
Short Title: Survival in Follicular Lymphoma
2017
Serum Biomarkers Predict Outcomes in Advanced Hodgkin Lymphoma Independent of International Prognostic Score (IPS) and Treatment: Correlative Analysis from a Large North American Cooperative Group Trial
Blood·2016· 4 cited
Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499
Leukemia·2016· 15 citedOpen Access
Randomized phase 3 study in low‐grade lymphoma comparing maintenance anti‐CD20 antibody with observation after induction therapy: A trial of the ECOG‐ACRIN Cancer Research Group (E1496)
Cancer·2016· 32 citedOpen Access
Rituximab extended schedule or retreatment trial for low tumour burden non‐follicular indolent B‐cell non‐Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402
British Journal of Haematology·2016· 48 citedOpen Access
Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis
Blood·2015· 5 cited
page 1 of 16Next →

Frequent Co-authors

Richard T. Hoppe(16), Randy D. Gascoyne(13), Richard I. Fisher(11), Ranjana H. Advani(11), Nancy L. Bartlett(10), Joseph M. Connors(9), Saul A. Rosenberg(8), Edie Weller(6), Leo I. Gordon(6), Fangxin Hong(6), Brad S. Kahl(6), Bruce D. Cheson(5), Anton Hagenbeek(5), Thomas M. Habermann(5), Mary Gospodarowicz(4), Karl G. Blume(4), Patrick J. Stiff(4), Jamés O. Armitage(3), George P. Canellos(3), Tim Lister(3)